510(k) K252102

Alinity m HCV by Abbott Molecular, Inc. — Product Code MZP

K252102 is an FDA 510(k) premarket notification submitted by Abbott Molecular, Inc. for the device "Alinity m HCV". The FDA issued a decision of Substantially Equivalent on September 25, 2025. The device falls under product code MZP (Assay, Hybridization And/Or Nucleic Acid Amplification For Detection Of Hepatitis C Rna,Hepatitis C Virus), a Class II device regulated under 21 CFR 866.3170. Abbott Molecular, Inc. has at least 10 other 510(k) clearances on record.

Clearance Details

Decision
SESE (Substantially Equivalent)
Decision Date
September 25, 2025
Date Received
July 3, 2025
Clearance Type
Traditional
Expedited Review
No
Third Party Review
No

Device Classification

Device Name
Assay, Hybridization And/Or Nucleic Acid Amplification For Detection Of Hepatitis C Rna,Hepatitis C Virus
Device Class
Class II
Regulation Number
866.3170
Review Panel
MI
Submission Type